- Home
- LSTA vs SKYH.WS Comparison
LSTA vs SKYH.WS Comparison
Compare LSTA & SKYH.WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.20
Company Overview
Basic Information| Metric | LSTA | SKYH.WS |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.0M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSTA | SKYH.WS |
|---|---|---|
| Price | $1.20 | $0.28 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 108.7K | 63.7K |
| Earning Date | 11-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $0.96 | $0.17 |
| 52 Week High | $5.07 | $0.29 |
Technical Indicators
Market Signals| Indicator | LSTA | SKYH.WS |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | N/A |
| Support Level | $1.23 | N/A |
| Resistance Level | $1.28 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 56.18 | 0.00 |
Price Performance
Historical Comparison LSTA
SKYH.WS
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.